ID: ALA243041

Max Phase: Preclinical

Molecular Formula: C21H19N3OS

Molecular Weight: 361.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC(=S)Nc1ccc(OCCn2c3ccccc3c3ccccc32)cc1

Standard InChI:  InChI=1S/C21H19N3OS/c22-21(26)23-15-9-11-16(12-10-15)25-14-13-24-19-7-3-1-5-17(19)18-6-2-4-8-20(18)24/h1-12H,13-14H2,(H3,22,23,26)

Standard InChI Key:  NXZWOHQDWDBTTO-UHFFFAOYSA-N

Associated Targets(non-human)

RAW 181 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 361.47Molecular Weight (Monoisotopic): 361.1249AlogP: 4.53#Rotatable Bonds: 5
Polar Surface Area: 52.21Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.89CX Basic pKa: CX LogP: 4.75CX LogD: 4.75
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.51Np Likeness Score: -1.22

References

1. Kim YJ, Ryu JH, Cheon YJ, Lim HJ, Jeon R..  (2007)  Design and synthesis of urea and thiourea derivatives and their inhibitory activities on lipopolysaccharide-induced NO production.,  17  (12): [PMID:17467989] [10.1016/j.bmcl.2007.04.005]

Source